Back    Zoom +    Zoom -
Wang Wentao Engages with US PhRMA/ Multinational Pharmaceutical Executives on Development in CN
Recommend
15
Positive
24
Negative
15
Chinese Minister of Commerce Wang Wentao held a meeting last Saturday (21st) with Stephen Ubl, President and CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA), as well as executives from five multinational pharmaceutical companies including Novartis, AstraZeneca, and Roche Group. The discussions focused on the development and concerns of foreign pharmaceutical companies in China.

Wang stated that the "15th Five-Year Plan" clearly propounds the implementation of a health-first development strategy, designating biopharmaceuticals as an emerging pillar industry, strengthening intellectual property protection, and improving policy transparency and regulatory efficiency. These measures provide new opportunities for multinational pharmaceutical companies to fully participate in the "Healthy China" initiative.

Related NewsM Stanley Lists Top 50 CN/HK Holdings Among Long-only EM & CN Active Managers (Table)

AASTOCKS Financial News
Website: www.aastocks.com